Equity Plans and Stock-based Compensation (Tables)

3 Months Ended

Apr. 30, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Expense

The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s condensed consolidated statements of operations:


	Three Months Ended April 30,
	2026		2025
	(in thousands)
Cost of revenue	$	991	$	1,223
Research and development	5,432		8,614
Sales and marketing	1,882		3,079
General and administrative	2,290		4,947
Total stock-based compensation expense	$	10,595	$	17,863

Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity

A summary of RSUs outstanding under the 2021 EIP as of April 30, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Shares	Weighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 2026	2,195,297	$	26.56
RSU granted	26,601	$	6.38
RSU vested	(289,681)	$	41.19
RSU forfeited	(173,812)	$	26.95
Outstanding as of April 30, 2026	1,758,405	$	23.80

A summary of PRSUs outstanding under the 2021 EIP as of April 30, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Shares	Weighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 2026	444,933	$	23.22
PRSUs granted	—	$	—

PRSU forfeited	—	$	—
Outstanding as of April 30, 2026	444,933	$	23.22

Share-based Payment Arrangement, Option, Activity

A summary of options outstanding under the 2017 Plan and 2007 Plan as of April 30, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Stock Option Awards	Weighted Average Exercise Price		Weighted Average Remaining Contractual term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2026	118,756	$	15.51	3.1	$	—

Options expired	(3,145)	$	12.67
Outstanding as of April 30, 2026	115,611	$	15.58	2.8	$	—
Options vested and expected to vest as of April 30, 2026	115,611	$	15.58	2.8	$	—
Exercisable as of April 30, 2026	115,611	$	15.58	2.8	$	—